View Activity

Faculty

Adam S. Fleisher, MD, MAS
Associate Professor, Department of Neurosciences
University of California San Diego
San Diego, California
Director of Brain Imaging
Banner Alzheimer’s Institute
Phoenix, Arizona

Program Overview

This case-based enduring activity will cover the diagnosis, treatment and management of patients with Alzheimer’s disease (AD).

Target Audience

This activity is designed to meet the educational needs of neurologists, imaging technologists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s Disease.

Learning Objectives

Upon completion of the program, attendees should be able to:

  • Discuss how evidence-based guidelines for AD diagnosis can be incorporated into neurology practice and the current use of AD biomarkers
  • Review the clinical data regarding brain imaging in AD including amyloid-PET imaging for the detection of cortical fibrillary amyloid in patients with cognitive impairment
  • Assess the importance of diagnosis in AD and the challenges encountered
  • Apply the criteria for appropriate use of amyloid-PET as recommended in a recent report from AITF, SNMM and AA
  • Discuss how the use of biomarkers will optimize clinical trials design and guide therapeutic decisions in clinical practice in the contest of emerging therapies

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation Statement

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure of Conflicts of Interest

Dr. Adam Fleisher received consulting and/or speaker fees from Avid Radiopharmaceuticals, Grifols, Eli Lilly and Company, Merck and Co., Inc., and Quintiles and is also a DSMB member for Merck and Co., Inc., NIA and Pfizer Inc. He is on the speakers’ bureaus for Avid Radiopharmaceuticals, Quintiles and Siemens. He received contracted research funding from Avanir Pharmaceuticals, Bristol-Myers Squibb, Genentech/Roche, Merck and Co., Inc., Pfizer Inc, Takeda Pharmaceutical Company Limited, and Wyeth (Pfizer). Dr. Fleisher has received grant funding from Eli Lilly and Company, and NIA.

Course Reviewer

Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania

MLG Course Reviewer – Dr. Katherine Galluzzi has no relevant financial relationships to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Kelly Kraines, Director of CME/CE for Med Learning Group has nothing to disclose.
Flavia Piazza, VP, Medical and Scientific Services for Med Learning Group has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Fleisher may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CE credit participants must:

  1. Read the learning objectives and faculty disclosures.
  2. Complete the pre-test.
  3. Participate in the enduring activity.
  4. Complete the post-test and activity evaluation.
  5. Physicians who successfully complete the post-test and evaluation will receive CME credit.
  6. All non-physician participants who successfully complete the post-test and evaluation will receive a certificate of participation.
  7. You will receive your certificate via email within 30 days.

For CME questions, please contact: Med Learning Group at
info@medlearninggroup.com

Contact this CME provider for privacy and confidentiality policy statement information at:
http://www.medlearninggroup.com/privacy-policy/

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Course Viewing Requirements

PC: Firefox, Chrome, or Internet Explorer (version 8 or greater)
Mac: Firefox, Chrome, or Safari

Release Date: November 29, 2013
Expiration Date: November 28, 2014

Medium: Internet

Course Topic: Alzheimer’s Disease

Estimated Time to Complete This Educational Activity: 60 minutes

Acknowledgement

Med Learning Group
Sponsored by Med Learning Group

Supported by an Educational Grant from Lilly USA, LLC

Copyright © 2013 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

View Activity